微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 3.65% | 8.31% | 78.92% | 78/159 | 3.55% | 翰宇药业 | 52.19% | 行业排名> |
| 2026-06-30 | 2.04% | 14.61% | 164.94% | 85/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.77% | 40% | -81.17% | 94/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 4.09% | 135.06% | 21.36% | 67/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 3.37% | -2.6% | 89.33% | 81/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.78% | -19.09% | 223.64% | 84/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.55% | -58.96% | -68.39% | 96/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 1.74% | -62.09% | -49.71% | 92/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 3.46% | -41.46% | 57.27% | 78/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.2% | -38.55% | 64.18% | 76/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.34% | 27.62% | -70.81% | 79/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.59% | -27.83% | -22.34% | 67/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.91% | -16.53% | 65.08% | 58/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 3.58% | -0.56% | 240.95% | 58/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.05% | -15.32% | -83.49% | 88/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 6.36% | 115.59% | -10.17% | 61/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.08% | 21.65% | 96.67% | 52/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.6% | 9.09% | 190.32% | 61/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.24% | -16.78% | -57.97% | 84/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.95% | -67.29% | -49.31% | 90/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 5.82% | -24.9% | 76.36% | 69/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.3% | -32.52% | 121.48% | 76/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.49% | -12.87% | -83.48% | 78/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 9.02% | 97.81% | 16.39% | 62/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.75% | 19.6% | 58.49% | 50/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.89% | 10.63% | 185.96% | 56/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 1.71% | 12.5% | -62.5% | 57/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.56% | -40.7% | -29.63% | 89/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.48% | 9.46% | 46.61% | 55/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.42% | 10.22% | 190.79% | 57/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.52% | 2.01% | -80.23% | 68/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 7.69% | 29.03% | 29.9% | 68/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.92% | 21.06% | 47.63% | 57/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.01% | 57.87% | 169.13% | 57/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.49% | 33.04% | -75% | 68/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 5.96% | 8.36% | 21.88% | 78/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 4.89% | 4.71% | 92.52% | 64/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.54% | 1.2% | 126.79% | 75/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.12% | 38.27% | -79.64% | 61/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 5.5% | -8.49% | 17.77% | 78/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.67% | -18.92% | 86.06% | 53/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 2.51% | -39.81% | 209.88% | 62/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.81% | -59.9% | -86.52% | 62/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |